Clinical trials
Active, not recruiting Phase 3 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
673 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 8 |
| 2016 | 6 |
| 2017 | 17 |
| 2018 | 26 |
| 2019 | 29 |
| 2020 | 62 |
| 2021 | 96 |
| 2022 | 100 |
| 2023 | 107 |
| 2024 | 130 |
| 2025 | 73 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 673 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 69 |
| Hoffmann-La Roche | 33 |
| Merck Sharp & Dohme LLC | 33 |
| Novartis Pharmaceuticals | 31 |
| Janssen Research & Development, LLC | 26 |
| Eli Lilly and Company | 23 |
| AbbVie | 19 |
| Sanofi | 18 |
| Sun Yat-sen University | 17 |
| Jiangsu HengRui Medicine Co., Ltd. | 14 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 66 |
| Breast Neoplasms | 49 |
| Nasopharyngeal Carcinoma | 20 |
| Multiple Myeloma | 17 |
| Neoplasms | 15 |
| Neoplasm Metastasis | 13 |
| Carcinoma, Hepatocellular | 11 |
| Lymphoma, Non-Hodgkin | 11 |
| Obesity | 11 |
| Prostatic Neoplasms | 11 |
Trials
Showing 1 to 25 of 673. Each trial links to its page on Pharma Observatory.
573 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.